News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,976 Results
Type
Article (2632)
Company Profile (43)
Press Release (38301)
Multimedia
Podcasts (11)
Webinars (2)
Section
Business (14221)
Career Advice (79)
Deals (2126)
Drug Delivery (9)
Drug Development (4161)
Employer Resources (10)
FDA (446)
Job Trends (789)
News (20331)
Policy (1057)
Tag
Academia (146)
Allergies (7)
Alliances (3492)
ALS (6)
Alzheimer's disease (66)
Antibody-drug conjugate (ADC) (47)
Approvals (456)
Artificial intelligence (43)
Autoimmune disease (23)
Automation (4)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (22)
Biotechnology (29)
Bladder cancer (10)
Brain cancer (8)
Breast cancer (54)
Cancer (412)
Cardiovascular disease (13)
Career advice (66)
Career pathing (1)
CAR-T (42)
CDC (2)
Cell therapy (102)
Cervical cancer (5)
Clinical research (3570)
Collaboration (248)
Company closure (3)
Compensation (130)
COVID-19 (187)
CRISPR (12)
C-suite (157)
Cystic fibrosis (8)
Data (564)
Denatured (6)
Depression (12)
Dermatology (1)
Diabetes (20)
Diagnostics (500)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (46)
Drug pricing (10)
Duchenne muscular dystrophy (58)
Earnings (4670)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6611)
Executive appointments (147)
FDA (622)
Friedreich's ataxia (7)
Frontotemporal dementia (1)
Funding (215)
Gene editing (39)
Generative AI (3)
Gene therapy (73)
GLP-1 (76)
Government (162)
Guidances (24)
Healthcare (721)
HIV (3)
Huntington's disease (6)
IgA nephropathy (16)
Immunology and inflammation (39)
Immuno-oncology (17)
Indications (11)
Infectious disease (207)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (38)
Interviews (7)
IPO (1004)
IRA (7)
Job creations (294)
Job search strategy (62)
JPM (4)
Kidney cancer (7)
Labor market (12)
Layoffs (52)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (6)
Lung cancer (39)
Lymphoma (13)
Machine learning (3)
Management (4)
Manufacturing (75)
MASH (19)
Medical device (316)
Medtech (321)
Mergers & acquisitions (1249)
Metabolic disorders (97)
mRNA (12)
Multiple sclerosis (26)
Neurodegenerative disease (36)
Neuropsychiatric disorders (11)
Neuroscience (191)
NextGen: Class of 2026 (354)
Non-profit (157)
Now hiring (16)
Obesity (47)
Opinion (18)
Ovarian cancer (26)
Pain (33)
Pancreatic cancer (26)
Parkinson's disease (15)
Partnered (4)
Patents (68)
Patient recruitment (51)
Peanut (1)
People (5981)
Pharmaceutical (3)
Phase 1 (1534)
Phase 2 (1762)
Phase 3 (950)
Pipeline (706)
Policy (17)
Postmarket research (30)
Preclinical (661)
Press Release (2)
Prostate cancer (8)
Psychedelics (4)
Radiopharmaceuticals (18)
Rare diseases (87)
Real estate (425)
Recruiting (5)
Regulatory (967)
Reports (7)
Research institute (150)
Resumes & cover letters (9)
Rett syndrome (2)
RNA editing (5)
RSV (2)
Schizophrenia (17)
Series A (57)
Series B (25)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (502)
Stomach cancer (3)
Supply chain (6)
Tariffs (2)
The Weekly (5)
Vaccines (62)
Venture capital (17)
Weight loss (27)
Women's health (18)
Worklife (1)
Date
Today (5)
Last 7 days (43)
Last 30 days (275)
Last 365 days (2387)
2026 (1102)
2025 (2439)
2024 (2608)
2023 (2858)
2022 (3750)
2021 (4047)
2020 (3471)
2019 (2060)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (46)
Alabama (3)
Arizona (20)
Asia (1992)
Australia (308)
California (1935)
Canada (297)
China (106)
Colorado (69)
Connecticut (18)
Delaware (10)
Europe (4099)
Florida (72)
Georgia (16)
Hawaii (2)
Idaho (3)
Illinois (27)
India (3)
Indiana (73)
Japan (21)
Kansas (15)
Kentucky (1)
Maryland (69)
Massachusetts (705)
Michigan (15)
Minnesota (27)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (163)
New York (101)
North Carolina (156)
Northern California (984)
Ohio (56)
Oklahoma (2)
Oregon (7)
Pennsylvania (137)
Puerto Rico (1)
Rhode Island (3)
South America (40)
South Carolina (2)
Southern California (782)
Tennessee (5)
Texas (184)
United States (3904)
Utah (7)
Virginia (14)
Washington D.C. (3)
Washington State (110)
West Virginia (1)
Wisconsin (16)
40,976 Results for "ideaya biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IDEAYA Biosciences Announces Participation at the 2026 Jefferies Global Healthcare Conference
May 26, 2026
·
2 min read
Press Releases
IDEAYA Biosciences Announces Clinical Collaboration with Roche in MTAP-Deleted RAS-Mutant Pancreatic Cancer
June 3, 2026
·
5 min read
Press Releases
IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update
May 5, 2026
·
14 min read
Press Releases
IDEAYA Biosciences Announces Upcoming Presentations at AACR 2026 Highlighting Multiple Clinical Stage Pipeline Programs
March 19, 2026
·
5 min read
Cancer
GSK Cuts Five-Year-Old Cancer Collaboration With Ideaya
GSK and Ideaya first linked up in 2020 to advance novel therapies for solid tumors. It is unclear why the pharma terminated the partnership.
December 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
IDEAYA Biosciences to Participate in Upcoming February 2026 Investor Relations Events
February 2, 2026
·
2 min read
Press Releases
IDEAYA Biosciences to Initiate New Drug Application Submission from the Darovasertib OptimUM-02 Trial under the Oncology Center of Excellence Real-time Oncology Review (RTOR) Program
April 30, 2026
·
5 min read
Press Releases
IDEAYA Biosciences to Announce Topline Results from Phase 2/3 OptimUM-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026
April 12, 2026
·
1 min read
Press Releases
IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Late-Breaking Oral Presentation at ASCO
June 2, 2026
·
10 min read
Press Releases
IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial
March 23, 2026
·
3 min read
1 of 4,098
Next
